Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-13,700
Closed -$666K 1296
2024
Q1
$666K Hold
13,700
0.01% 730
2023
Q4
$681K Hold
13,700
0.01% 619
2023
Q3
$735K Hold
13,700
0.01% 526
2023
Q2
$738K Buy
+13,700
New +$737K 0.01% 456
2022
Q2
Sell
-53,180
Closed -$2.73M 1452
2022
Q1
$2.73M Sell
53,180
-60,147
-53% -$3.11M 0.03% 470
2021
Q4
$5.68M Buy
113,327
+68,327
+152% +$3.38M 0.06% 242
2021
Q3
$2.17M Buy
+45,000
New +$2.29M 0.02% 433
2020
Q1
Sell
-13,277
Closed -$667K 421
2019
Q4
$667K Buy
+13,277
New +$622K ﹤0.01% 270

Other funds holding SNY

LMR Partners's SNY Position: Q2 2024 in Review

LMR Partners sold out of Sanofi (SNY) in Q2 2024, closing a stake of 13,700 shares — an estimated $666K sold.

LMR Partners first reported a position in SNY in Q4 2019 and held it in 8 quarters. The position peaked at $5.68M in Q4 2021. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

  • LMR Partners reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
  • LMR Partners sold 13,700 Sanofi shares in Q2 2024, an estimated $666K.
  • LMR Partners first reported a position in Sanofi in Q4 2019 and held it in 8 quarters.
  • LMR Partners's Sanofi position peaked at $5.68M in Q4 2021.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on LMR Partners's 13F filing for Q2 2024, filed 14 Aug 2024.